- Home
- NTZ vs VTVT Comparison
NTZ vs VTVT Comparison
Compare NTZ & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- VTVT
- Stock Information
- Founded
- NTZ 1959
- VTVT 2015
- Country
- NTZ Italy
- VTVT United States
- Employees
- NTZ N/A
- VTVT N/A
- Industry
- NTZ Home Furnishings
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- NTZ Consumer Discretionary
- VTVT Health Care
- Exchange
- NTZ Nasdaq
- VTVT Nasdaq
- Market Cap
- NTZ 49.5M
- VTVT 56.7M
- IPO Year
- NTZ 1993
- VTVT 2015
- Fundamental
- Price
- NTZ $4.28
- VTVT $15.89
- Analyst Decision
- NTZ
- VTVT Strong Buy
- Analyst Count
- NTZ 0
- VTVT 2
- Target Price
- NTZ N/A
- VTVT $35.50
- AVG Volume (30 Days)
- NTZ 6.3K
- VTVT 5.8K
- Earning Date
- NTZ 06-20-2025
- VTVT 05-15-2025
- Dividend Yield
- NTZ N/A
- VTVT N/A
- EPS Growth
- NTZ N/A
- VTVT N/A
- EPS
- NTZ N/A
- VTVT N/A
- Revenue
- NTZ $330,051,765.00
- VTVT $17,000.00
- Revenue This Year
- NTZ N/A
- VTVT N/A
- Revenue Next Year
- NTZ N/A
- VTVT N/A
- P/E Ratio
- NTZ N/A
- VTVT N/A
- Revenue Growth
- NTZ N/A
- VTVT N/A
- 52 Week Low
- NTZ $3.07
- VTVT $12.12
- 52 Week High
- NTZ $6.27
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- NTZ 61.35
- VTVT 34.47
- Support Level
- NTZ $3.07
- VTVT $15.91
- Resistance Level
- NTZ $4.32
- VTVT $18.09
- Average True Range (ATR)
- NTZ 0.19
- VTVT 1.09
- MACD
- NTZ 0.12
- VTVT -0.68
- Stochastic Oscillator
- NTZ 96.80
- VTVT 5.09
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.